Docusign Inc. (NASDAQ:DOCU – Get Free Report) CEO Allan Thygesen sold 26,250 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $47.78, for a total value of $1,254,225.00. Following the completion of the sale, the chief executive officer owned 152,237 shares in the company, valued at $7,273,883.86. The trade was a 14.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Docusign Price Performance
Shares of DOCU opened at $48.37 on Friday. The stock has a market capitalization of $9.40 billion, a P/E ratio of 32.68, a P/E/G ratio of 1.88 and a beta of 0.99. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $94.67. The company has a 50 day moving average of $47.40 and a 200-day moving average of $61.71.
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. During the same quarter in the previous year, the firm posted $0.86 earnings per share. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. On average, sell-side analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.
Analyst Ratings Changes
DOCU has been the subject of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research note on Tuesday, March 10th. Royal Bank Of Canada dropped their price objective on Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a research note on Wednesday, March 18th. Jefferies Financial Group downgraded Docusign from a “buy” rating to a “hold” rating and reduced their target price for the stock from $105.00 to $45.00 in a research note on Monday, February 23rd. Morgan Stanley decreased their target price on Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a report on Wednesday, March 18th. Finally, BTIG Research restated a “buy” rating and issued a $70.00 price target on shares of Docusign in a research note on Wednesday, March 18th. Five investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $64.67.
Get Our Latest Report on Docusign
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Central Pacific Bank Trust Division bought a new stake in shares of Docusign during the fourth quarter worth approximately $25,000. Modus Advisors LLC bought a new position in shares of Docusign during the fourth quarter worth approximately $27,000. Torren Management LLC bought a new position in shares of Docusign during the fourth quarter worth approximately $28,000. Aventura Private Wealth LLC acquired a new stake in Docusign during the 4th quarter worth approximately $30,000. Finally, True Wealth Design LLC lifted its holdings in Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the last quarter. 77.64% of the stock is owned by institutional investors.
Key Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
- Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
- Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
- Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
- Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
- Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
- Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Articles
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
